26 results on '"Sastry, Mallika"'
Search Results
2. Interprotomer disulfide-stabilized variants of the human metapneumovirus fusion glycoprotein induce high titer-neutralizing responses
- Author
-
Stewart-Jones, Guillaume B. E., Gorman, Jason, Ou, Li, Zhang, Baoshan, Joyce, M. Gordon, Yang, Lijuan, Cheng, Cheng, Chuang, Gwo-Yu, Foulds, Kathryn E., Kong, Wing-Pui, Olia, Adam S., Sastry, Mallika, Shen, Chen-Hsiang, Todd, John-Paul, Tsybovsky, Yaroslav, Verardi, Raffaello, Yang, Yongping, Collins, Peter L., Corti, Davide, Lanzavecchia, Antonio, Scorpio, Diana G., Mascola, John R., Buchholz, Ursula J., and Kwong, Peter D.
- Published
- 2021
3. Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1
- Author
-
Xu, Kai, Acharya, Priyamvada, Kong, Rui, Cheng, Cheng, Chuang, Gwo-Yu, Liu, Kevin, Louder, Mark K., O’Dell, Sijy, Rawi, Reda, Sastry, Mallika, Shen, Chen-Hsiang, Zhang, Baoshan, Zhou, Tongqing, Asokan, Mangaiarkarasi, Bailer, Robert T., Chambers, Michael, Chen, Xuejun, Choi, Chang W., Dandey, Venkata P., Doria-Rose, Nicole A., Druz, Aliaksandr, Eng, Edward T., Farney, S. Katie, Foulds, Kathryn E., Geng, Hui, Georgiev, Ivelin S., Gorman, Jason, Hill, Kurt R., Jafari, Alexander J., Kwon, Young D., Lai, Yen-Ting, Lemmin, Thomas, McKee, Krisha, Ohr, Tiffany Y., Ou, Li, Peng, Dongjun, Rowshan, Ariana P., Sheng, Zizhang, Todd, John-Paul, Tsybovsky, Yaroslav, Viox, Elise G., Wang, Yiran, Wei, Hui, Yang, Yongping, Zhou, Amy F., Chen, Rui, Yang, Lu, Scorpio, Diana G., McDermott, Adrian B., Shapiro, Lawrence, Carragher, Bridget, Potter, Clinton S., Mascola, John R., and Kwong, Peter D.
- Published
- 2018
- Full Text
- View/download PDF
4. Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus
- Author
-
McLellan, Jason S., Chen, Man, Joyce, M. Gordon, Sastry, Mallika, Stewart-Jones, Guillaume B. E., Yang, Yongping, Zhang, Baoshan, Chen, Lei, Srivatsan, Sanjay, Zheng, Anqi, Zhou, Tongqing, Graepel, Kevin W., Kumar, Azad, Moin, Syed, Boyington, Jeffrey C., Chuang, Gwo-Yu, Soto, Cinque, Baxa, Ulrich, Bakker, Arjen Q., Spits, Hergen, Beaumont, Tim, Zheng, Zizheng, Xia, Ningshao, Ko, Sung-Youl, Todd, John-Paul, Rao, Srinivas, Graham, Barney S., and Kwong, Peter D.
- Published
- 2013
- Full Text
- View/download PDF
5. Mapping monoclonal anti-SARS-CoV-2 antibody repertoires against diverse coronavirus antigens.
- Author
-
Oliveira de Souza, Matheus, Madan, Bharat, I-Ting Teng, Huang, Aric, Lihong Liu, Fahad, Ahmed S., Acevedo, Sheila N. Lopez, Xiaoli Pan, Sastry, Mallika, Gutierrez-Gonzalez, Matias, Yin, Michael T., Tongqing Zhou, Ho, David D., Kwong, Peter D., and DeKosky, Brandon J.
- Subjects
SARS-CoV-2 ,MONOCLONAL antibodies - Abstract
Variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have emerged continuously, challenging the effectiveness of vaccines, diagnostics, and treatments. Moreover, the possibility of the appearance of a new betacoronavirus with high transmissibility and high fatality is reason for concern. In this study, we used a natively paired yeast display technology, combined with next-generation sequencing (NGS) and massive bioinformatic analysis to perform a comprehensive study of subdomain specificity of natural human antibodies from two convalescent donors. Using this screening technology, we mapped the cross-reactive responses of antibodies generated by the two donors against SARS-CoV-2 variants and other betacoronaviruses. We tested the neutralization potency of a set of the cross-reactive antibodies generated in this study and observed that most of the antibodies produced by these patients were non-neutralizing. We performed a comparison of the specific and non-specific antibodies by somatic hypermutation in a repertoire-scale for the two individuals and observed that the degree of somatic hypermutation was unique for each patient. The data from this study provide functional insights into crossreactive antibodies that can assist in the development of strategies against emerging SARS-CoV-2 variants and divergent betacoronaviruses. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
6. Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9
- Author
-
McLellan, Jason S., Pancera, Marie, Carrico, Chris, Gorman, Jason, Julien, Jean-Philippe, Khayat, Reza, Louder, Robert, Pejchal, Robert, Sastry, Mallika, Dai, Kaifan, O’Dell, Sijy, Patel, Nikita, Shahzad-ul-Hussan, Syed, Yang, Yongping, Zhang, Baoshan, Zhou, Tongqing, Zhu, Jiang, Boyington, Jeffrey C., Chuang, Gwo-Yu, Diwanji, Devan, Georgiev, Ivelin, Do Kwon, Young, Lee, Doyung, Louder, Mark K., Moquin, Stephanie, Schmidt, Stephen D., Yang, Zhi-Yong, Bonsignori, Mattia, Crump, John A., Kapiga, Saidi H., Sam, Noel E., Haynes, Barton F., Burton, Dennis R., Koff, Wayne C., Walker, Laura M., Phogat, Sanjay, Wyatt, Richard, Orwenyo, Jared, Wang, Lai-Xi, Arthos, James, Bewley, Carole A., Mascola, John R., Nabel, Gary J., Schief, William R., Ward, Andrew B., Wilson, Ian A., and Kwong, Peter D.
- Published
- 2011
- Full Text
- View/download PDF
7. Mammalian production of an isotopically enriched outer domain of the HIV-1 gp120 glycoprotein for NMR spectroscopy
- Author
-
Sastry, Mallika, Xu, Ling, Georgiev, Ivelin S., Bewley, Carole A., Nabel, Gary J., and Kwong, Peter D.
- Published
- 2011
- Full Text
- View/download PDF
8. Solid-phase synthesis of backbone-cyclized β-helical peptides
- Author
-
Clark, Thomas D., Sastry, Mallika, Brown, Christopher, and Wagner, Gerhard
- Published
- 2006
- Full Text
- View/download PDF
9. Accelerated acquisition of high resolution triple-resonance spectra using non-uniform sampling and maximum entropy reconstruction
- Author
-
Rovnyak, David, Frueh, Dominique P., Sastry, Mallika, Sun, Zhen-Yu J., Stern, Alan S., Hoch, Jeffrey C., and Wagner, Gerhard
- Published
- 2004
- Full Text
- View/download PDF
10. Solution structure of the mithramycin dimer-DNA complex
- Author
-
Sastry, Mallika and Patel, Dinshaw J.
- Subjects
Plicamycin -- Usage ,DNA -- Research ,Biological sciences ,Chemistry - Abstract
Techniques involving NMR-molecular dynamics and relaxation matrix refinement were utilised in the structure analysis of complexes produced from Mg2+-coordinated mithramycin dimer binding to self-complementary d(T-G-G-C-C-A) and d(T-C-G-C-G-A) duplexes. The molecular structure of the mithramycin dimer d(T-C-G-C-G-A) reveals a two-fold center of symmetry. The aglycon C-8 hydroxyl oxygens are hydrogen bonded to guanine amino protons in the complex due to the positioning of divalent cation coordinated glycons, opposite the central (G3-C4). (G3-C4) segment.
- Published
- 1993
11. Cyclic peptide helices: A hybrid [Beta]-hairpin/[beta]-helical supersecondary structure
- Author
-
Sastry, Mallika, Brown, Christopher, Wagner, Gerhard, and Clark, Thomas D.
- Subjects
Peptides -- Analysis ,Helicases -- Structure ,Chemistry - Abstract
The design of a new peptide motif that is a hybrid of Beta-hairpin and Beta-helical supersecondary structures is described. The results of characterization of the peptide motif confirm success of the design of the motif and emphasize that hybrid [Beta]-hairpin/[Beta]-helical constructs described were characterized only in nonpolar organic solvents.
- Published
- 2006
12. Consistent elicitation of cross-clade HIV-neutralizing responses achieved in guinea pigs after fusion peptide priming by repetitive envelope trimer boosting.
- Author
-
Cheng, Cheng, Xu, Kai, Kong, Rui, Chuang, Gwo-Yu, Corrigan, Angela R., Geng, Hui, Hill, Kurt R., Jafari, Alexander J., O’Dell, Sijy, Ou, Li, Rawi, Reda, Rowshan, Ariana P., Sarfo, Edward K., Sastry, Mallika, Saunders, Kevin O., Schmidt, Stephen D., Wang, Shuishu, Wu, Winston, Zhang, Baoshan, and Doria-Rose, Nicole A.
- Subjects
GUINEA pigs ,IMMUNIZATION ,ANTIBODY formation ,MONOCLONAL antibodies ,HIV - Abstract
The vaccine elicitation of broadly neutralizing responses is a central goal of HIV research. Recently, we elicited cross-clade neutralizing responses against the N terminus of the fusion peptide (FP), a critical component of the HIV-entry machinery. While the consistency of the elicited cross-clade neutralizing responses was good in mice, it was poor in guinea pigs: after seven immunizations comprising either envelope (Env) trimer or FP coupled to a carrier, serum from only one of five animals could neutralize a majority of a cross-clade panel of 19 wild-type strains. Such a low response rate—only 20%—made increasing consistency an imperative. Here, we show that additional Env-trimer immunizations could boost broad FP-directed neutralizing responses in a majority of immunized animals. The first boost involved a heterologous Env trimer developed from the transmitted founder clade C strain of donor CH505, and the second boost involved a cocktail that combined the CH505 trimer with a trimer from the BG505 strain. After boosting, sera from three of five animals neutralized a majority of the 19-strain panel and serum from a fourth animal neutralized 8 strains. We demonstrate that cross-reactive serum neutralization targeted the FP by blocking neutralization with soluble fusion peptide. The FP competition revealed two categories of elicited responses: an autologous response to the BG505 strain of high potency (~10,000 ID
50 ), which was not competed by soluble FP, and a heterologous response of lower potency, which was competed by soluble FP. While the autologous response could increase rapidly in response to Env-trimer boost, the heterologous neutralizing response increased more slowly. Overall, repetitive Env-trimer immunizations appeared to boost low titer FP-carrier primed responses to detectable levels, yielding cross-clade neutralization. The consistent trimer-boosted neutralizing responses described here add to accumulating evidence for the vaccine utility of the FP site of HIV vulnerability. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
13. Soluble Prefusion Closed DS-SOSIP.664-Env Trimers of Diverse HIV-1 Strains.
- Author
-
Joyce, M. Gordon, Georgiev, Ivelin S., Yongping Yang, Druz, Aliaksandr, Hui Geng, Gwo-Yu Chuang, Young Do Kwon, Pancera, Marie, Rawi, Reda, Sastry, Mallika, Stewart-Jones, Guillaume B. E., Angela Zheng, Tongqing Zhou, Misook Choe, Van Galen, Joseph G., Chen, Rita E., Lees, Christopher R., Narpala, Sandeep, Chambers, Michael, and Tsybovsky, Yaroslav
- Abstract
The elicitation of autologous neutralizing responses by immunization with HIV-1 envelope (Env) trimers conformationally stabilized in a prefusion closed state has generated considerable interest in the HIV-1 vaccine field. However, soluble prefusion closed Env trimers have been produced from only a handful of HIV-1 strains, limiting their utility as vaccine antigens and B cell probes. Here, we report the engineering from 81 HIV-1 strains of soluble, fully cleaved, prefusion Env trimers with appropriate antigenicity. We used a 96-well expression-screening format to assess the ability of artificial disulfides and Ile559Pro substitution (DS-SOSIP) to produce soluble cleaved-Env trimers; from 180 Env strains, 20 yielded prefusion closed trimers. We also created chimeras, by utilizing structure-based design to incorporate select regions from the well-behaved BG505 strain; from 180 Env strains, 78 DS-SOSIPstabilized chimeras, including 61 additional strains, yielded prefusion closed trimers. Structure-based design thus enables the production of prefusion closed HIV-1-Env trimers from dozens of diverse strains. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
14. Adjuvants and the vaccine response to the DS-Cav1-stabilized fusion glycoprotein of respiratory syncytial virus.
- Author
-
Sastry, Mallika, Zhang, Baoshan, Chen, Man, Joyce, M. Gordon, Kong, Wing-Pui, Chuang, Gwo-Yu, Ko, Kiyoon, Kumar, Azad, Silacci, Chiara, Thom, Michelle, Salazar, Andres M., Corti, Davide, Lanzavecchia, Antonio, Taylor, Geraldine, Mascola, John R., Graham, Barney S., and Kwong, Peter D.
- Subjects
- *
RESPIRATORY syncytial virus , *GLYCOPROTEINS , *VACCINE effectiveness , *IMMUNE response , *RESPIRATORY syncytial virus infection vaccines - Abstract
Appropriate adjuvant selection may be essential to optimize the potency and to tailor the immune response of subunit vaccines. To induce protective responses against respiratory syncytial virus (RSV)—a highly prevalent childhood pathogen without a licensed vaccine—we previously engineered a pre-fusion-stabilized trimeric RSV F (pre-F) “DS-Cav1” immunogen, which induced high titer RSV-neutralizing antibodies, in mice and non-human primates, when formulated with adjuvants Poly (I:C) and Poly (IC:LC), respectively. To assess the impact of different adjuvants, here we formulated RSV F DS-Cav1 with multiple adjuvants and assessed immune responses. Very high RSV-neutralizing antibody responses (19,006 EC50) were observed in naïve mice immunized with 2 doses of DS-Cav1 adjuvanted with Sigma adjuvant system (SAS), an oil-in-water adjuvant, plus Carbopol; high responses (3658–7108) were observed with DS-Cav1 adjuvanted with Alum, SAS alone, Adjuplex, Poly (I:C) and Poly (IC:LC); and moderate responses (1251–2129) were observed with DS-Cav1 adjuvanted with the TLR4 agonist MPLA, Alum plus MPLA or AddaVax. In contrast, DS-Cav1 without adjuvant induced low-level responses (6). A balanced IgG1 and IgG2a (Th2/Th1) immune response was elicited in most of the high to very high response groups (all but Alum and Adjuplex). We also tested the immune response induced by DS-Cav1 in elderly mice with pre-existing DS-Cav1 immunity; we observed that DS-Cav1 adjuvanted with SAS plus Carbopol boosted the response 2-3-fold, whereas DS-Cav1 adjuvanted with alum boosted the response 5-fold. Finally, we tested whether a mixture of ISA 71 VG and Carbopol would enhanced the antibody response in DS-Cav1 immunized calves. While pre-F-stabilized bovine RSV F induced very high titers in mice when adjuvanted with SAS plus Carbopol, the addition of Carbopol to ISA 71 VG did not enhance immune responses in calves. The vaccine response to pre-F-stabilized RSV F is augmented by adjuvant, but the degree of adjuvant-induced enhancement appears to be both context-dependent and species-specific. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
15. Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation.
- Author
-
Zhou, Tongqing, Doria-Rose, Nicole A., Cheng, Cheng, Stewart-Jones, Guillaume B.E., Chuang, Gwo-Yu, Chambers, Michael, Druz, Aliaksandr, Geng, Hui, McKee, Krisha, Kwon, Young Do, O’Dell, Sijy, Sastry, Mallika, Schmidt, Stephen D., Xu, Kai, Chen, Lei, Chen, Rita E., Louder, Mark K., Pancera, Marie, Wanninger, Timothy G., and Zhang, Baoshan
- Abstract
Summary While the HIV-1-glycan shield is known to shelter Env from the humoral immune response, its quantitative impact on antibody elicitation has been unclear. Here, we use targeted deglycosylation to measure the impact of the glycan shield on elicitation of antibodies against the CD4 supersite. We engineered diverse Env trimers with select glycans removed proximal to the CD4 supersite, characterized their structures and glycosylation, and immunized guinea pigs and rhesus macaques. Immunizations yielded little neutralization against wild-type viruses but potent CD4-supersite neutralization (titers 1: >1,000,000 against four-glycan-deleted autologous viruses with over 90% breadth against four-glycan-deleted heterologous strains exhibiting tier 2 neutralization character). To a first approximation, the immunogenicity of the glycan-shielded protein surface was negligible, with Env-elicited neutralization (ID 50 ) proportional to the exponential of the protein-surface area accessible to antibody. Based on these high titers and exponential relationship, we propose site-selective deglycosylated trimers as priming immunogens to increase the frequency of site-targeting antibodies. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
16. Insights from NMR Spectroscopy into the Conformational Properties of Man-9 and Its Recognition by Two HIV Binding Proteins.
- Author
-
Shahzad‐ul‐Hussan, Syed, Sastry, Mallika, Lemmin, Thomas, Soto, Cinque, Loesgen, Sandra, Scott, Danielle A., Davison, Jack R., Lohith, Katheryn, O'Connor, Robert, Kwong, Peter D., and Bewley, Carole A.
- Published
- 2017
- Full Text
- View/download PDF
17. Thermoresponsive Polymer Nanoparticles Co-deliver RSV F Trimers with a TLR-7/8 Adjuvant.
- Author
-
Francica, Joseph R., Lynn, Geoffrey M., Laga, Richard, Joyce, M. Gordon, Ruckwardt, Tracy J., Morabito, Kaitlyn M., Man Chen, Chaudhuri, Rajoshi, Baoshan Zhang, Sastry, Mallika, Druz, Aliaksandr, Kiyoon Ko, Misook Choe, Pechar, Michal, Georgiev, Ivelin S., Kueltzo, Lisa A., Seymour, Leonard W., Mascola, John R., Kwong, Peter D., and Graham, Barney S.
- Published
- 2016
- Full Text
- View/download PDF
18. Structure-Based Design of Head-Only Fusion Glycoprotein Immunogens for Respiratory Syncytial Virus.
- Author
-
Boyington, Jeffrey C., Joyce, M. Gordon, Sastry, Mallika, Stewart-Jones, Guillaume B. E., Chen, Man, Kong, Wing-Pui, Ngwuta, Joan O., Thomas, Paul V., Tsybovsky, Yaroslav, Yang, Yongping, Zhang, Baoshan, Chen, Lei, Druz, Aliaksandr, Georgiev, Ivelin S., Ko, Kiyoon, Zhou, Tongqing, Mascola, John R., Graham, Barney S., and Kwong, Peter D.
- Subjects
RESPIRATORY syncytial virus ,CHIMERIC proteins ,GLYCOPROTEINS ,AGE factors in disease ,GENETIC mutation ,NEUTRALIZATION (Chemistry) - Abstract
Respiratory syncytial virus (RSV) is a significant cause of severe respiratory illness worldwide, particularly in infants, young children, and the elderly. Although no licensed vaccine is currently available, an engineered version of the metastable RSV fusion (F) surface glycoprotein—stabilized in the pre-fusion (pre-F) conformation by “DS-Cav1” mutations—elicits high titer RSV-neutralizing responses. Moreover, pre-F-specific antibodies, often against the neutralization-sensitive antigenic site Ø in the membrane-distal head region of trimeric F glycoprotein, comprise a substantial portion of the human response to natural RSV infection. To focus the vaccine-elicited response to antigenic site Ø, we designed a series of RSV F immunogens that comprised the membrane-distal head of the F glycoprotein in its pre-F conformation. These “head-only” immunogens formed monomers, dimers, and trimers. Antigenic analysis revealed that a majority of the 70 engineered head-only immunogens displayed reactivity to site Ø-targeting antibodies, which was similar to that of the parent RSV F DS-Cav1 trimers, often with increased thermostability. We evaluated four of these head-only immunogens in detail, probing their recognition by antibodies, their physical stability, structure, and immunogenicity. When tested in naïve mice, a head-only trimer, half the size of the parent RSV F trimer, induced RSV titers, which were statistically comparable to those induced by DS-Cav1. When used to boost DS-Cav1-primed mice, two head-only RSV F immunogens, a dimer and a trimer, boosted RSV-neutralizing titers to levels that were comparable to those boosted by DS-Cav1, although with higher site Ø-directed responses. Our results provide proof-of-concept for the ability of the smaller head-only RSV F immunogens to focus the vaccine-elicited response to antigenic site Ø. Decent primary immunogenicity, enhanced physical stability, potential ease of manufacture, and potent immunogenicity upon boosting suggest these head-only RSV F immunogens, engineered to retain the pre-fusion conformation, may have advantages as candidate RSV vaccines. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
19. Prefusion F–specific antibodies determine the magnitude of RSV neutralizing activity in human sera.
- Author
-
Ngwuta, Joan O., Chen, Man, Modjarrad, Kayvon, Joyce, M. Gordon, Masaru Kanekiyo, Kumar, Azad, Yassine, Hadi M., Moin, Syed M., Killikelly, April M., Gwo-Yu Chuang, Druz, Aliaksandr, Georgiev, Ivelin S., Rundlet, Emily J., Sastry, Mallika, Stewart-Jones, Guillaume B. E., Yongping Yang, Zhang, Baoshan, Nason, Martha C., Capella, Cristina, and Peeples, Mark E.
- Subjects
RESPIRATORY syncytial virus ,SERUM ,MUTANT proteins ,MONOCLONAL antibodies ,VACCINATION - Abstract
The article presents research conducted by Joan O. Ngwuta on the activity of perfusion F-specific antibodies in determining the magnitude of Respiratory syncytial virus (RSV) neutralizing activity in human sera. Topics discussed include protein competition assays with perfusion F mutants to knock out binding corresponding sites; detection of site-specific antibodies by competition assays with monoclonal antibodies; and boosting of neutralizing activity by vaccination.
- Published
- 2015
- Full Text
- View/download PDF
20. A Cysteine Zipper Stabilizes a Pre-Fusion F Glycoprotein Vaccine for Respiratory Syncytial Virus.
- Author
-
Stewart-Jones, Guillaume B. E., Thomas, Paul V., Chen, Man, Druz, Aliaksandr, Joyce, M. Gordon, Kong, Wing-Pui, Sastry, Mallika, Soto, Cinque, Yang, Yongping, Zhang, Baoshan, Chen, Lei, Chuang, Gwo-Yu, Georgiev, Ivelin S., McLellan, Jason S., Srivatsan, Sanjay, Zhou, Tongqing, Baxa, Ulrich, Mascola, John R., Graham, Barney S., and Kwong, Peter D.
- Subjects
RESPIRATORY syncytial virus infection vaccines ,CYSTEINE ,GLYCOPROTEINS ,CHIMERIC proteins ,PROTEIN conformation ,MONOMERS - Abstract
Recombinant subunit vaccines should contain minimal non-pathogen motifs to reduce potential off-target reactivity. We recently developed a vaccine antigen against respiratory syncytial virus (RSV), which comprised the fusion (F) glycoprotein stabilized in its pre-fusion trimeric conformation by “DS-Cav1” mutations and by an appended C-terminal trimerization motif or “foldon” from T4-bacteriophage fibritin. Here we investigate the creation of a cysteine zipper to allow for the removal of the phage foldon, while maintaining the immunogenicity of the parent DS-Cav1+foldon antigen. Constructs without foldon yielded RSV F monomers, and enzymatic removal of the phage foldon from pre-fusion F trimers resulted in their dissociation into monomers. Because the native C terminus of the pre-fusion RSV F ectodomain encompasses a viral trimeric coiled-coil, we explored whether introduction of cysteine residues capable of forming inter-protomer disulfides might allow for stable trimers. Structural modeling indicated the introduced cysteines to form disulfide “rings”, with each ring comprising a different set of inward facing residues of the coiled-coil. Three sets of rings could be placed within the native RSV F coiled-coil, and additional rings could be added by duplicating portions of the coiled-coil. High levels of neutralizing activity in mice, equivalent to that of the parent DS-Cav1+foldon antigen, were elicited by a 4-ring stabilized RSV F trimer with no foldon. Structure-based alteration of a viral coiled-coil to create a cysteine zipper thus allows a phage trimerization motif to be removed from a candidate vaccine antigen. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
21. Rational design of a functional metalloenzyme: introduction of a site for manganese binding and oxidation into a heme peroxidase
- Author
-
Wilcox, Sheri K., Putnam, Christopher D., Sastry, Mallika, Blankenship, John, Chazin, Walter J., McRee, Duncan E., and Goodin, David B.
- Subjects
Peroxidase -- Research ,Metalloenzymes -- Research ,Hemoproteins -- Research ,Biological sciences ,Chemistry - Abstract
A functional model for the oxidation of manganese (Mn2+) in manganese peroxidase (MnP) through the enlistment of inherent oxidizing potential of another peroxidase was examined. The construction and structural properties of Mn2+ binding sites near the heme of cytochrome c peroxidase (CCP) were described. The CCP demonstrated 20% amino acid sequence identity and structural similarity to MnP even without the binding sites observed in MnP. The findings confirmed that the presence of Mn2+ caused paramagnetic broadening of two proton resonances in the upfield area of the spectrum.
- Published
- 1998
22. A Structural Basis for S100 Protein Specificity Derived from Comparative Analysis of Apo and Ca2+-Calcyclin
- Author
-
Mäler, Lena, Sastry, Mallika, and Chazin, Walter J.
- Subjects
- *
GENETIC transduction , *CARRIER proteins , *NUCLEAR magnetic resonance - Abstract
Calcyclin is a homodimeric protein belonging to the S100 subfamily of EF-hand Ca2+-binding proteins, which function in Ca2+ signal transduction processes. A refined high-resolution solution structure of Ca2+-bound rabbit calcyclin has been determined by heteronuclear solution NMR. In order to understand the Ca2+-induced structural changes in S100 proteins, in-depth comparative structural analyses were used to compare the apo and Ca2+-bound states of calcyclin, the closely related S100B, and the prototypical Ca2+-sensor protein calmodulin. Upon Ca2+ binding, the position and orientation of helix III in the second EF-hand is altered, whereas the rest of the protein, including the dimer interface, remains virtually unchanged. This Ca2+-induced structural change is much less drastic than the “opening” of the globular EF-hand domains that occurs in classical Ca2+ sensors, such as calmodulin. Using homology models of calcyclin based on S100B, a binding site in calcyclin has been proposed for the N-terminal domain of annexin XI and the C-terminal domain of the neuronal calcyclin-binding protein. The structural basis for the specificity of S100 proteins is discussed in terms of the variation in sequence of critical contact residues in the common S100 target-binding site. [Copyright &y& Elsevier]
- Published
- 2002
- Full Text
- View/download PDF
23. Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a pH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding Domains.
- Author
-
Zhou, Tongqing, Tsybovsky, Yaroslav, Gorman, Jason, Rapp, Micah, Cerutti, Gabriele, Chuang, Gwo-Yu, Katsamba, Phinikoula S., Sampson, Jared M., Schön, Arne, Bimela, Jude, Boyington, Jeffrey C., Nazzari, Alexandra, Olia, Adam S., Shi, Wei, Sastry, Mallika, Stephens, Tyler, Stuckey, Jonathan, Teng, I-Ting, Wang, Pengfei, and Wang, Shuishu
- Abstract
The SARS-CoV-2 spike employs mobile receptor-binding domains (RBDs) to engage the human ACE2 receptor and to facilitate virus entry, which can occur through low-pH-endosomal pathways. To understand how ACE2 binding and low pH affect spike conformation, we determined cryo-electron microscopy structures—at serological and endosomal pH—delineating spike recognition of up to three ACE2 molecules. RBDs freely adopted "up" conformations required for ACE2 interaction, primarily through RBD movement combined with smaller alterations in neighboring domains. In the absence of ACE2, single-RBD-up conformations dominated at pH 5.5, resolving into a solitary all-down conformation at lower pH. Notably, a pH-dependent refolding region (residues 824–858) at the spike-interdomain interface displayed dramatic structural rearrangements and mediated RBD positioning through coordinated movements of the entire trimer apex. These structures provide a foundation for understanding prefusion-spike mechanics governing endosomal entry; we suggest that the low pH all-down conformation potentially facilitates immune evasion from RBD-up binding antibody. • Determine cryo-EM structures of SARS-CoV-2 spike along its endosomal entry pathway • Reveal structural basis by which a pH-dependent switch mediates RBD positioning • Show spike to exclusively adopt an all-RBD-down conformation at low pH • Suggest low-pH all-RBD-down conformation to provide a basis for immune evasion Zhou et al. determine 12 structures of the SARS-CoV-2 spike, bound by ACE2 receptor and ligand free, that reveal a pH-dependent switch to mediate positioning of spike receptor-binding domains (RBDs). At low pH, the spike adopts an all-RBD-down conformation, which provides a potential means of immune evasion from RBD-up-recognizing antibody. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
24. Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerability.
- Author
-
Shi, Wei, Wang, Lingshu, Zhou, Tongqing, Sastry, Mallika, Yang, Eun Sung, Zhang, Yi, Chen, Man, Chen, Xuejun, Choe, Misook, Creanga, Adrian, Leung, Kwan, Olia, Adam S., Pegu, Amarendra, Rawi, Reda, Schön, Arne, Shen, Chen-Hsiang, Stancofski, Erik-Stephane D., Talana, Chloe Adrienna, Teng, I-Ting, and Wang, Shuishu
- Subjects
- *
SARS-CoV-2 , *MONOCLONAL antibodies , *IMMUNOGLOBULINS - Abstract
Immunization with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike elicits diverse antibodies, but it is unclear if any of the antibodies can neutralize broadly against other beta-coronaviruses. Here, we report antibody WS6 from a mouse immunized with mRNA encoding the SARS-CoV-2 spike. WS6 bound diverse beta-coronavirus spikes and neutralized SARS-CoV-2 variants, SARS-CoV, and related sarbecoviruses. Epitope mapping revealed WS6 to target a region in the S2 subunit, which was conserved among SARS-CoV-2, Middle East respiratory syndrome (MERS)-CoV, and hCoV-OC43. The crystal structure at 2 Å resolution of WS6 revealed recognition to center on a conserved S2 helix, which was occluded in both pre- and post-fusion spike conformations. Structural and neutralization analyses indicated WS6 to neutralize by inhibiting fusion and post-viral attachment. Comparison of WS6 with other recently identified antibodies that broadly neutralize beta-coronaviruses indicated a stem-helical supersite—centered on hydrophobic residues Phe1148, Leu1152, Tyr1155, and Phe1156—to be a promising target for vaccine design. [Display omitted] • Antibody WS6 from SARS-CoV-2 spike-immunized mice binds diverse beta-CoV spikes • WS6 neutralizes SARS-CoV-2 variants, SARS-CoV, and related sarbecoviruses • Crystal structure of WS6 with a conserved S2 peptide reveals a helical epitope • WS6 epitope belongs to an S2 supersite recognized by diverse antibodies Shi et al. identified a broad beta-coronavirus neutralizing antibody from mice immunized with mRNA encoding the SARS-CoV-2 spike. This antibody targets an S2 supersite comprising a hydrophobic cluster spanning three helical turns, which are conserved among beta-coronaviruses. This S2 supersite appears to be a good target for broad beta-coronavirus vaccines. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
25. Single-Chain Soluble BG505.SOSIP gp140 Trimers as Structural and Antigenic Mimics of Mature Closed HIV-1 Env.
- Author
-
Georgiev, Ivelin S., Joyce, M. Gordon, Yongping Yang, Sastry, Mallika, Zhang, Baoshan, Baxa, Ulrich, Chen, Rita E., Druz, Aliaksandr, Lees, Christopher R., Narpala, Sandeep, Schön, Arne, Van Galen, Joseph, Gwo-Yu Chuang, Gorman, Jason, Harned, Adam, Pancera, Marie, Stewart-Jones, Guillaume B. E., Cheng Cheng, Freire, Ernesto, and McDermott, Adrian B.
- Subjects
- *
GLYCOPROTEINS , *PROTEOLYTIC enzymes , *HIV , *EPITOPES , *IMMUNOGLOBULINS - Abstract
Similar to other type I fusion machines, the HIV-1 envelope glycoprotein (Env) requires proteolytic activation; specifically, cleavage of a gp160 precursor into gp120 and gp41 subunits creates an N-terminal gp41 fusion peptide and permits folding from an immature uncleaved state to a mature closed state. While the atomic-level consequences of cleavage for HIV-1 Env are still being determined, the uncleaved state is antigenically distinct from the mature closed state, and cleavage has been reported to be essential for mimicry of the mature viral spike by soluble versions of Env. Here we report the redesign of a current state-of-the-art soluble Env mimic, BG505.SOSIP, to make it cleavage independent. Specifically, we replaced the furin cleavage site between gp120 and gp41 with Gly-Ser linkers of various lengths. The resultant linked gp120-gp41 constructs, termed single-chain gp140 (sc-gp140), exhibited different levels of structural and antigenic mimicry of the parent cleaved BG505.SOSIP. When constructs were subjected to negative selection to remove subspecies recognized by poorly neutralizing antibodies, trimers of high antigenic mimicry of BG505.SOSIP could be obtained; negative-stain electron microscopy indicated these to resemble the mature closed state. Higher proportions of BG505.SOSIP-trimer mimicry were observed in sc-gp140s with linkers of 6 or more residues, with a linker length of 15 residues exhibiting especially promising traits. Overall, flexible linkages between gp120 and gp41 in BG505.SOSIP can thus substitute for cleavage, and sc-gp140s that closely mimicked the vaccine-preferred mature closed state of Env could be obtained. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
26. Longitudinal Analysis Reveals Early Development of Three MPER-Directed Neutralizing Antibody Lineages from an HIV-1-Infected Individual.
- Author
-
Krebs, Shelly J., Kwon, Young D., Schramm, Chaim A., Law, William H., Donofrio, Gina, Zhou, Kenneth H., Gift, Syna, Dussupt, Vincent, Georgiev, Ivelin S., Schätzle, Sebastian, McDaniel, Jonathan R., Lai, Yen-Ting, Sastry, Mallika, Zhang, Baoshan, Jarosinski, Marissa C., Ransier, Amy, Chenine, Agnes L., Asokan, Mangaiarkarasi, Bailer, Robert T., and Bose, Meera
- Subjects
- *
IMMUNOGLOBULINS - Abstract
Summary Lineage-based vaccine design is an attractive approach for eliciting broadly neutralizing antibodies (bNAbs) against HIV-1. However, most bNAb lineages studied to date have features indicative of unusual recombination and/or development. From an individual in the prospective RV217 cohort, we identified three lineages of bNAbs targeting the membrane-proximal external region (MPER) of the HIV-1 envelope. Antibodies RV217-VRC42.01, -VRC43.01, and -VRC46.01 used distinct modes of recognition and neutralized 96%, 62%, and 30%, respectively, of a 208-strain virus panel. All three lineages had modest levels of somatic hypermutation and normal antibody-loop lengths and were initiated by the founder virus MPER. The broadest lineage, VRC42, was similar to the known bNAb 4E10. A multimeric immunogen based on the founder MPER activated B cells bearing the unmutated common ancestor of VRC42, with modest maturation of early VRC42 intermediates imparting neutralization breadth. These features suggest that VRC42 may be a promising template for lineage-based vaccine design. Graphical Abstract Highlights • Multiple MPER-directed bNAb lineages developed in a single individual • The broadest lineage belongs to the same antibody class as the 4E10 antibody • Low levels of somatic hypermutation of the RV217-VRC42 lineage can impart breadth • A multimeric immunogen activates VRC42 precursor B cells Despite extensive structural work, little is known about how MPER-specific HIV antibodies develop. Krebs et al. describe the initiation and early development of three MPER-directed HIV broadly neutralizing antibody lineages from a single donor of the RV217 cohort. One of the antibody lineages appears particularly promising for vaccine design, as it achieved high neutralizing breadth with low mutation from germline. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.